Scarica l'app Stockscreener
8.38
1.18%
-0.10
Dopo l'orario di chiusura:
8.32
-0.06
-0.72%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHC Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bausch Health Companies Inc Borsa (BHC) Ultime notizie
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug - Marketscreener.com
Herpes Zoster Oticus Market: Company Profiles, Segment Sizes, - openPR
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis - AccessWire
Bausch Health's Triple-Action Acne Treatment CABTREO Gains Key Canadian Approvals | BHC Stock News - StockTitan
Common Warts Treatment Market Trade Analysis and Statistical - openPR
Underactive Bladder Treatment Market Expected to Reach Huge - openPR
Genital Herpes Treatment Market Global Share, Trends, Business - openPR
Varicella Zoster (HHV-3) Infections Treatment Market Share, - openPR
Vitrectomy Devices Market is expected to reach US$ 2121.3 - openPR
22q11.2 Deletion Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Nobias Therapeutics, Zynerba Pharma, Bausch Health Americas - The Globe and Mail
Actinic Keratosis Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyze | Bausch Health Companies, Sandoz Pharma, Athenex, Almirall, Vidac Pharma, G&E Herbal Biotech - Barchart
Periodontal Therapeutics Market to Grow at a Promising CAGR - openPR
Myopia and Presbyopia Treatment Market to Grow by USD 9.76 Billion from 2024-2028, as Rising Prevalence Drives Demand with AI Redefining Market LandscapeTechnavio - The Malaysian Reserve
Are Medical Stocks Lagging Bausch Health (BHC) This Year? - MSN
Body Contouring Treatments Market to Hit USD 2.58 Billion by 2029 with 10.0% CAGR | MarketsandMarkets™ - The Manila Times
Eye Health Supplements Market Trends and Growth Projections - openPR
Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend InsightsTechnavio - The Malaysian Reserve
189,000 Shares in Bausch Health Companies Inc. (NYSE:BHC) Bought by Intact Investment Management Inc. - MarketBeat
Bausch Health Companies' SWOT analysis: debt woes cloud strong Q3 stock performance - Investing.com
Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Bausch Health Q3 Earnings and Revenues Top, Xifaxan Boosts Sales - MSN
Bausch Health Companies Inc. (NYSE:BHC) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Bausch Health secures $400 million loan amendment - Investing.com
Bausch Health secures $400 million loan amendment By Investing.com - Investing.com UK
Bausch Health Companies (NYSE:BHC) Price Target Raised to $11.00 at Royal Bank of Canada - MarketBeat
Bausch Health Companies Inc. (NYSE:BHC) Q3 2024 Earnings Call Transcript - Insider Monkey
Bausch Health Companies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Bausch Health stock outlook lifted as RBC cites robust Q3 growth and tax benefits - Investing.com
Traders Purchase High Volume of Bausch Health Companies Put Options (NYSE:BHC) - MarketBeat
Toronto Stocks Drop, Canada's GDP Flat in August; Bausch Health Rises on 3Q Beat - Marketscreener.com
Bausch Health Shares Rise on FY Outlook Upgrade, 3Q Beat - MarketWatch
Bausch Health Companies (NYSE:BHC) Trading 8.7% Higher on Better-Than-Expected Earnings - MarketBeat
Bausch Health Companies (TSE:BHC) Stock Price Up 8.4% Following Earnings Beat - MarketBeat
BHCBausch Health Companies Inc. Latest Stock News & Market Updates - StockTitan
Bausch: Q3 Earnings Snapshot - Houston Chronicle
Bausch Health Reports Growth Amid Improved Financials - TipRanks
Compared to Estimates, Bausch (BHC) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Bausch Health (BHC) Beats Q3 Earnings and Revenue Estimates - Yahoo Finance
Bausch Health Companies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Bausch Health Announces Third Quarter 2024 Results - AccessWire
Gastroparesis Treatment Market Top Trends and Growth Analysis: - openPR
Bausch Health Companies Q3 2024 Earnings Preview - MSN
Onychomycosis Treatment Market Size, Industry Analysis, - openPR
Actinic Keratosis Treatment Market Expected to Reach Huge - openPR
Canada Aesthetic Devices Market Size, Share, Industry Growth, - openPR
Bausch Health Companies Inc. and Salix Pharmaceuticals Announce Results of an Analysis of Xifaxan Monotherapy Will Be Presented During A Presidential Plenary Session of the American College of Gastroenterology 2024 Annual Scientific Meeting Taking - Marketscreener.com
ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence - StockTitan
TD COWEN Downgrades Bausch Health Companies (BHC) - MSN
Deal Dispatch: TKO Buys Bull Riding, Radford Motors Is BankruptApollo Global Management (NYSE:APO), Bausch Health Companies (NYSE:BHC) - Benzinga
Bausch Health Companies (NYSE:BHC) Lifted to "Buy" at StockNews.com - MarketBeat
FY2024 EPS Estimates for TSE:BHC Lifted by Zacks Research - MarketBeat
2024 Research | Europe Retinal Surgery Devices Market Poised for Growth, Expected to Reach $1.16 Billion by 2032, Driven by Rising Prevalence of Retinal Diseases and Technological Advancements - GlobeNewswire Inc.
Bausch Health (BHC) Reports Next Week: What to Expect - Yahoo Finance
What is Zacks Research's Forecast for BHC Q3 Earnings? - MarketBeat
Zacks Research Has Positive Outlook for TSE:BHC Q3 Earnings - MarketBeat
Bausch Health Companies (BHC) Set to Announce Earnings on Wednesday - MarketBeat
Bausch Health Companies (BHC) Scheduled to Post Earnings on Wednesday - MarketBeat
Contact Lenses Market Forecast: Segments, Drivers, and Growth - openPR
0.79%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):